| Literature DB >> 29876130 |
Tomohiro Mimura1, Kanji Mori1, Yuki Furuya1, Shin Itakura1, Taku Kawasaki1, Shinji Imai1.
Abstract
The coexistence of acetabular dysplasia (AD) and femoroacetabular impingement (FAI) has not been well discussed. This study was performed to elucidate the prevalence and morphological features of AD with coexisting FAI-related findings in a Japanese population. Computed tomography images were retrospectively evaluated. AD was classified as definite or borderline. The morphological findings that defined cam deformity were an α angle of ≥55°, head-neck offset ratio (HNOR) of <0.13, pistol grip deformity positivity and herniation pit positivity. The morphological findings that defined pincer deformity were acetabular index of ≤0° and a retroverted acetabulum. In total, 128 hips (male, 64; female, 64) were analyzed. The prevalence of coexistence of AD and FAI-related findings was detected in 23.4% of hips (definite AD and FAI, 7.8%; borderline AD and FAI, 15.6%). The percentages of hips with AD containing cam or pincer deformities among all were 54.3% and 4.3%, respectively. The percentage of AD with coexisting cam and that of AD with coexisting combined deformities was significantly higher in men, respectively. On the other hand, the most major morphological feature of FAI detected in hips with AD was a HNOR of <0.13. The coexistence of AD and FAI-related findings was common in a Japanese population, and 65.2% of hips with AD had some FAI-related findings. In discussing and managing AD, we recommend paying attention to the coexistence with FAI-related findings, especially in men and in borderline AD. In such hips, the most notable parameter as a morphological feature of FAI is a reduced HNOR.Entities:
Year: 2018 PMID: 29876130 PMCID: PMC5961138 DOI: 10.1093/jhps/hny006
Source DB: PubMed Journal: J Hip Preserv Surg ISSN: 2054-8397
Fig. 1.Measurement of CE angle, Sharp angle and AI. These angles were measured on a slice of femoral head center in the coronal plane. θ1, θ2, and θ3 is CE angle, Sharp angle and AI, respectively. CE angle was measured as the angle between the line joining the lateral aspect of the acetabulum and the femoral head center, and the line perpendicular to the line parallel to the transverse axis of the pelvis. Sharp angle was measured as the angle between the line joining the lateral aspect of the weight bearing zone and the inferior point of teardrop, and the line parallel to the transverse axis of the pelvis. AI was measured as the angle between the line joining the medial and lateral aspects of the weight bearing zone, and the line parallel to the transverse axis of the pelvis.
Fig. 2.Measurement of the acetabular version angle in four axial slices. (A) Reference plane for measuring the acetabular version angle. Each line represents one of the four slices; a slice at the level of the superior margin of the femoral head (slice A1), a slice 5 mm below the superior margin of the femoral head (slice A2), a slice 10 mm below the superior margin of the femoral head (slice A3) and a slice 15 mm below the superior margin of the femoral head (slice A4). (B) Axial slice of A1. Angle ø is the acetabular version angle.
Fig. 3.Measurement of the α-angle and HNOR in multiple radial slices (clockwise system). (A) Reference plane for measuring the α-angle and HNOR. The dotted line is the axis through the center of the femoral neck. It is adjusted to be parallel to the femoral neck–shaft angle. The solid line is the reference plane for radial angle reconstruction. (B) The reconstructed three-dimensional image demonstrates superimposed radial reference lines at 15° intervals. R1 (3:00 o’clock) is the oblique axial slice (dotted line in A). R2 (2:30 o’clock) is a plane rotated 15° from R1. R3 (2:00 o’clock) is a plane rotated 30° from R1. R4 (1:30 o’clock) is a plane rotated 45° from R1. R5 (1:00 o’clock) is a plane rotated 60° from R1. R6 (12:30 o’clock) is a plane rotated 75° from R1. (C) Angle ø is the α-angle. The α-angle is the angle between the line joining the center of the femoral head and the center of the femoral neck, and the line from the center of the femoral head to the point where the spherical image of the femoral head is lost. The HNOR was calculated by dividing the anterior offset (asterisk) by the maximum diameter of the femoral head of each slice. The anterior offset is the thickness of the femoral head that lies anterior to a line passing the anterior wall of the femoral neck that is parallel to a line crossing the center of the femoral head and neck.
Fig. 4.We defined an HP as a cystic-like lesion underneath the anterior cortex at the anterosuperior femoral head–neck junction with clear demarcation and a diameter of >3 mm. A HP (arrow) was evaluated in multiradial six slices.
Fig. 5.The presence of a PGD was subjectively judged on reconstructed three-dimensional reconstructed computed tomography images. This case was judged to be PGD-positive bilaterally (arrow).
Mean age and data for each parameter in all patients, men and women
| All subjects (128 hips) | Males (64 hips) | Females (64 hips) | ||
|---|---|---|---|---|
| Age (years) | 56.3±15.8 (21–84) | 57.2±16.1(21–83) | 55.5±15.48 (31–84) | 0.520 |
| CE angle (°) | 31.6±7.0 (15.4–47.8) | 32.3±6.5 (17.6–45.7) | 30.9±7.3 (15.4–47.8) | 0.315 |
| Sharp angle (°) | 40.1 ± 6.9 (31.8–54.8) | 39.3 ± 4.1 (31.8–54.8) | 40.9 ± 3.3 (31.9–49.1) | 0.003 |
| Acetabular index (°) | 6.7±9.2 (−7.9–22.8) | 6.6±11.3 (−7.5–22.8) | 6.8±6.4 (−7.9–22.3) | 0.195 |
| Acetabular version | ||||
| A1 (°) | 9.0±8.6 (−14.9–31.3) | 7.8±9.9 (−7.2–29.0) | 10.3±8.8 (−14.9–31.3) | 0.043 |
| A2 (°) | 12.0±9.0 (−10.6–34.0) | 9.9±8.6 (−7.5–34.0) | 14.0±8.8 (−10.6–32.7) | 0.003 |
| A3 (°) | 16.7±8.7 (−7.5–33.4) | 15.1±8.1 (−1.3–33.3) | 18.2±9.1 (−7.5–33.4) | 0.025 |
| A4 (°) | 19.6±7.8 (−3.8–35.6) | 18.2±6.8 (1.51–35.6) | 20.9±8.5 (−3.8–35.6) | 0.030 |
| α-angle | ||||
| R1 (°) | 40.3±5.1 (21.6–55.0) | 41.6±5.0 (30.5–55.0) | 39.0±5.0 (21.6–48.7) | 0.011 |
| R2 (°) | 42.8±5.7 (30.8–60.3) | 44.0±6.1 (30.8–60.3) | 41.7±4.9 (31.6–52.9) | 0.025 |
| R3 (°) | 46.0±5.9 (32.3–64.6) | 46.9±6.5 (32.3–64.6) | 45.0±5.1 (33.9–58.2) | 0.130 |
| R4 (°) | 48.5±5.9 (35.9–68.6) | 49.0±6.5 (35.9–68.6) | 47.9±5.2 (39.2–63.9) | 0.413 |
| R5 (°) | 49.0±6.9 (34.7–75.0) | 51.4±7.0 (39.2–75.0) | 47.7±5.9 (34.7–72.1) | <0.001 |
| R6 (°) | 46.9±7.4 (33.1–74.7) | 49.5±7.4 (34.1–74.7) | 44.3±4.9 (33.1–53.7) | <0.001 |
| HNOR | ||||
| R1 | 0.245±0.03 (0.159–0.371) | 0.243±0.03 (0.159–0.333) | 0.248±0.04 (0.165–0.371) | 0.504 |
| R2 | 0.241±0.07 (0.123–0.349) | 0.245±0.09 (0.123–0.305) | 0.236±0.04 (0.156–0.349) | 0.784 |
| R3 | 0.205±0.04 (0.080–0.336) | 0.211±0.05 (0.080–0.307) | 0.200±0.04 (0.115–0.336) | 0.099 |
| R4 | 0.167±0.05 (0.036–0.323) | 0.165±0.05 (0.036–0.306) | 0.168±0.04 (0.113–0.323) | 0.628 |
| R5 | 0.140±0.03 (0.054–0.270) | 0.136±0.03 (0.057–0.248) | 0.145±0.03 (0.054–0.270) | 0.113 |
| R6 | 0.141±0.03 (0.056–0.263) | 0.132±0.03 (0.056–0.191) | 0.150±0.03 (0.065–0.263) | 0.002 |
| HP positive | 17.2% (10.6%–23.7%) | 24.6% (17.14%–32.06%) | 9.2% (6.65%–11.75%) | 0.019 |
| PGD positive | 14.0% (7.98%–20.01%) | 20.0% (13.07%–26.92%) | 12.3% (17.32%–28.68%) | 0.041 |
Data are presented as mean ± standard deviation (range) or as percentage (95% CI). CE angle, center-edge angle; HNOR, head–neck offset ratio; HP, herniation pit; PGD, pistol grip deformity. A1, axial slice at the level of the superior margin of the femoral head; A2, axial slice 5 mm below the superior margin of the femoral head; A3, axial slice 10 mm below the superior margin of the femoral head; A4, axial slice 15 mm below the superior margin of the femoral head; R1, oblique axial plane through the center of the femoral neck, adjusted to be parallel to the femoral neck–shaft angle (3:00 o’clock); R2, radial plane cranially rotated 15° from R1 (2:30 o’clock); R3, radial plane cranially rotated 30° from R1 (2:00 o’clock); R4, radial plane cranially rotated 45° from R1 (1: 30 o’clock); R5, radial plane cranially rotated 60° from R1 (1: 00 o’clock); R6, radial plane cranially rotated 75° from R1 (12:30 o’clock).
Male versus female, evaluated with the Wilcoxon rank-sum test. P-values of <0.05 were considered statistically significant.
Male versus female, evaluated with χ2 test. P-values of <0.05 were considered statistically significant.
Detailed prevalence of AD and FAI-related findings in all patients, men, and women
| All subjects (128 hips) | Males (64 hips) | Females (64 hips) | ||
|---|---|---|---|---|
| Definite AD | ||||
| CE angle <20° | 6.3% (8/128) | 3.1% (2/64) | 9.4% (6/64) | 0.144 |
| [3.2%–11.8%] | [0.9%–10.7%] | [4.4%–19.0%] | ||
| Sharp angle >45° | 7.8% (10/128) | 6.3% (4/64) | 9.4% (6/64) | 0.439 |
| [4.3%–13.8%] | [2.5%–15.0%] | [4.4%–19.0%] | ||
| Total | 11.7% (15/128) | 7.8% (5/64) | 15.6% (10/64) | 0.169 |
| [7.2%–18.4%] | [3.4%–17.0%] | [8.7%–26.4%] | ||
| Borderline AD | ||||
| 20°≤ CE angle <25° | 12.5% (16/128) | 12.5% (8/64) | 12.5% (8/64) | 1 |
| [7.8%–19.3%] | [6.5%–22.8%] | [6.5%–22.8%] | ||
| 42°< Sharp angle ≤45° | 21.9% (28/128) | 15.6% (10/64) | 28.1% (18/64) | 0.087 |
| [15.6%–29.8%] | [8.7%–26.4%] | [18.6%–40.1%] | ||
| Total | 24.2% (31/128) | 21.9% (14/64) | 26.6% (17/64) | 0.536 |
| [17.6%–32.3%] | [13.5%–33.4%] | [17.3%–38.5%] | ||
| Cam deformity | ||||
| α angle ≥55° | 28.9% (37/128) | 40.6% (26/64) | 17.2% (11/64) | 0.003 |
| [21.8%–37.3%] | [29.5%–52.9%] | [9.9%–28.2%] | ||
| HNOR <0.13 | 58.6% (75/128) | 65.6% (42/64) | 51.6% (33/64) | 0.106 |
| [49.9%–66.9%] | [53.4%–76.1%] | [39.6%–63.4%] | ||
| PGD positive | 14.1% (18/128) | 20.3% (13/64) | 7.8% (5/64) | 0.041 |
| [9.1%–21.1%] | [12.3%–31.7%] | [3.4%–17.0%] | ||
| HP positive | 17.2% (22/128) | 25.0% (16/64) | 9.4% (6/64) | 0.016 |
| [11.6%–24.7%] | [16.0%–36.8%] | [4.4%–19.0%] | ||
| Total | 68.0% (87/128) | 79.7% (51/64) | 56.3% (36/64) | 0.004 |
| [59.5%–75.4%] | [68.3%–87.7%] | [44.1%–67.7%] | ||
| Pincer deformity | ||||
| Acetabular index ≤0° | 18.0% (23/128) | 20.3% (13/64) | 15.6% (10/64) | 0.489 |
| [12.3%–25.5%] | [12.3%–31.7%] | [8.7%–26.4%] | ||
| RA | 12.5% (16/128) | 17.2% (11/64) | 7.8% (5/64) | 0.108 |
| [7.8%–19.3%] | [9.9%–28.2%] | [3.4%–17.0%] | ||
| Total | 28.9% (37/128) | 37.5% (24/64) | 20.3% (13/64) | 0.031 |
| [21.8%–37.3%] | [26.7%–49.7%] | [12.3%–31.7%] | ||
| Combined deformity | 20.3% (26/128) | 28.1% (18/64) | 12.5% (8/64) | 0.028 |
| [14.3%–28.1%] | [18.6%–40.1%] | [6.5%–22.8%] | ||
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement; CE, center-edge angle; PGD, pistol grip deformity; HP, herniation pit; HNOR, head–neck offset ratio; RA, retroverted acetabulum.
Male versus female, evaluated with χ2 test. P-values of <0.05 were considered statistically significant.
Prevalence of each combination of coexistence of AD and FAI-related deformities
| All subjects (128 hips) | Males (64 hips) | Females (64 hips) | ||
|---|---|---|---|---|
| Definite AD and FAI-related deformities | 7.8% (10/128) | 7.8% (5/64) | 7.8% (5/64) | 1 |
| [4.3%–13.8%] | [3.4%–17.0%] | [3.4%–17.0%] | ||
| Definite AD + cam deformity | 6.3% (8/128) | 4.7% (3/64) | 7.8% (5/64) | 0.465 |
| [3.2%–11.8%] | [1.6%–12.9%] | [3.4%–17.0%] | ||
| Definite AD + pincer deformity | 0% (0/128) | 0% (0/64) | 0% (0/64) | – |
| [0%–2.9%] | [0%–5.7%] | [0%–5.7%] | ||
| Definite AD + combined deformity | 1.6% (2/128) | 3.1% (2/64) | 0% (0/64) | 0.154 |
| [0.4%–5.5%] | [0.9%–10.7%] | [0%–5.7%] | ||
| Borderline AD and FAI-related deformities | 15.6% (20/128) [10.3%–22.9%] | 20.3% (13/64) [12.3%–31.7%] | 10.9% (7/64) [5.4%–20.9%] | 0.144 |
| Borderline AD + cam deformity | 13.3% (17/128) [8.5%–20.2%] | 17.2% (11/64) [9.9%–28.2%] | 9.4% (6/64) [4.4%–19.0%] | 0.193 |
| Borderline AD + pincer deformity | 1.6% (2/128) | 1.6% (1/64) | 1.6% (1/64) | 1 |
| [0.4%–5.5%] | [0.3%–8.3%] | [0.3%–8.3%] | ||
| Borderline AD + combined deformity | 0.8% (1/128) | 1.6% (1/64) | 0% (0/64) | 0.315 |
| [0.1%–4.3%] | [0.3%–8.3%] | [0%–5.7%] | ||
| AD in total (definite and borderline) and FAI-related deformities | 23.4% (30/128) | 28.1% (18/64) | 18.7% (12/64) | 0.210 |
| [16.9%–31.5%] | [18.6%–40.1%] | [11.1%–30.0%] | ||
| AD in total (definite and borderline) + cam deformity | 19.5% (25/128) | 21.9% (14/64) | 17.2% (11/64) | 0.504 |
| [13.6%–27.2%] | [13.5%–33.4%] | [9.9%–28.2%] | ||
| AD in total (definite and borderline) + pincer deformity | 1.6% (2/128) | 1.6% (1/64) | 1.6% (1/64) | 1 |
| [0.4%–5.5%] | [0.3%–8.3%] | [0.3%–8.3%] | ||
| AD in total (definite and borderline) + combined deformity | 2.3% (3/128) | 4.7% (3/64) | 0% (0/64) | 0.079 |
| [0.8%–6.7%] | [1.6%–12.9%] | [0%–5.7%] |
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement.
Male versus female, evaluated with χ2 test. P-values of <0.05 were considered statistically significant.
Fig. 6.The representative case of the hip of AD with coexisting FAI-related findings. This case was 50 years old women, left hip was defined as a hip of borderline AD with coexisting cam deformity. (A) CE angle, Sharp angle and AI was 21°, 44° and 20°, respectively. (B) The acetabular version angle was 7° at a slice at the level of the superior margin of the femoral head (slice A1). (C) The α-angle and HNOR at a slice of R4 (1:30 o’clock) was 57° and 0.125, respectively. HP was also positive. (D) PGD was negative. According to the CE and Sharp angle, this hip was defined as a borderline AD. On the other hand, this hip was also defined as a cam deformity due to α-angle > 55°, HNOR < 0.13 and HP positive. However, this hip did not coexist with a pincer deformity, because the AI was over 0° and acetabular version angle was not negative.
Corresponding percentage of each type of AD with coexisting cam, pincer and combined deformities and without coexisting FAI-related findings compared with all numbers of each type of AD in all patients
| With coexisting cam deformity | With coexisting pincer deformity | With coexisting combined deformity | Without coexisting FAI-related findings | |
|---|---|---|---|---|
| Definite AD ( | 53.3% (8/15) | 0% (0/15) | 13.3% (2/15) | 33.3% (5/15) |
| [30.1%–75.2%] | [0%–20.4%] | [3.7%–37.9%] | [15.2%–58.3%] | |
| Borderline AD ( | 54.8% (17/31) | 6.5% (2/31) | 3.2% (1/31) | 35.5% (11/31) |
| [37.8%–70.8%] | [1.8%–20.7%] | [0.6%–16.2%] | [21.1%–53.1%] | |
| AD in total (definite and borderline) ( | 54.3% (25/46) | 4.3% (2/46) | 6.5% (3/46) | 34.8% (16/46) |
| [40.2%–67.8%] | [1.2%–14.5%] | [2.2%–17.5%] | [22.7%–49.2%] |
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement.
Comparison of corresponding percentage of AD with coexisting cam, pincer and combined deformities and without coexisting FAI-related findings compared with all numbers of each type of AD between men and women
| With coexisting cam deformity | With coexisting pincer deformity | With coexisting combined deformity | Without coexisting FAI-related findings | |||||
|---|---|---|---|---|---|---|---|---|
| Definite AD ( | Male | Female | Male | Female | Male | Female | Male | Female |
| 60% (3/5) | 50% (5/10) | 0% (0/5) | 0% (0/10) | 40% (2/5) | 0% (0/10) | 0%(0/5) | 50%(5/10) | |
| [23.1%–88.2%] | [23.7%–76.3%] | [0%–43.4%] | [0%–27.8%] | [11.8%–76.9%] | [0%–27.8%] | [0%–43.3%] | [23.7%–76.3%] | |
| − | − | − | − | |||||
| Borderline AD ( | Male | Female | Male | Female | Male | Female | Male | Female |
| 78.6% (11/14) | 35.3% (6/17) | 7.1% (1/14) | 5.9% (1/17) | 7.1% (1/14) | 0% (0/17) | 7.1% (1/14) | 58.8% (10/17) | |
| [52.4%–92.4%] | [17.3%–58.7%] | [1.3%–31.5%] | [1.0%–27.0%] | [1.3%–31.5%] | [0%–18.4%] | [1.3%–31.5%] | [36.0%–78.4%] | |
| − | − | − | − | |||||
| AD in total ( | Male | Female | Male | Female | Male | Female | Male | Female |
| 73.7% (14/19) | 40.7% (11/27) | 5.3% (1/19) | 3.7% (1/27) | 15.8% (3/19) | 0% (0/27) | 5.3% (1/19) | 55.6% (15/27) | |
| [51.2%–88.2%] | [24.5%–59.3%] | [0.9%–24.6%] | [0.7%–18.3%] | [5.5%–37.6%] | [0%–12.5%] | [0.9%–24.6%] | [37.3%–72.4%] | |
| − | − | − | − | |||||
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement. P values were evaluated with the χ2 test. P values of <0.05 were considered statistically significant.
Corresponding percentage of combination of coexistence with each type of AD and each FAI-related finding compared with all hips with coexistence of each type of AD (definite or borderline) and each FAI-related deformity (cam or pincer deformity)
| All subjects | Males | Females | ||
|---|---|---|---|---|
| Definite AD + cam deformity | ||||
| Definite AD + α angle ≥55° | 40% (4/10) | 40.0% (2/5) | 40.0% (2/5) | 1 |
| [16.8%–68.7%] | [11.8%–76.9%] | [11.8%–76.9%] | ||
| Definite AD + HNOR < 0.13 | 100% (10/10) | 100% (5/5) | 100% (5/5) | – |
| [72.2%–100%] | [56.6%–100%] | [56.6%–100%] | ||
| Definite AD + PGD positive | 10% (1/10) | 20% (1/5) | 0% (0/5) | 0.292 |
| [1.8%–40.4%] | [3.6%–62.4%] | [0%–43.3%] | ||
| Definite AD + HP positive | 20% (2/10) | 20% (1/5) | 20% (1/5) | 1 |
| [5.7%–51.0%] | [3.6%–62.4%] | [3.6%–62.4%] | ||
| Definite AD + pincer deformity | ||||
| Definite AD + acetabular index ≤0° | 0% (0/2) | 0% (0/2) | (0/0) | – |
| [0%–65.8%] | [0%–65.8%] | |||
| Definite AD + RA | 100% (2/2) | 100% (2/2) | (0/0) | – |
| [34.2%–100%] | [34.2%–100%] | |||
| Borderline AD + cam deformity | ||||
| Borderline AD + α angle ≥55° | 55.6% (10/18) | 41.7% (5/12) | 83.3% (5/6) | 0.094 |
| [33.7%–75.4%] | [19.3%–68.0%] | [43.6%–97.0%] | ||
| Borderline AD + HNOR < 0.13 | 88.9% (16/18) | 83.3% (10/12) | 100% (6/6) | 0.249 |
| [67.2%–96.9%] | [55.2%–95.3%] | [61.0%–100%] | ||
| Borderline AD + PGD positive | 27.8% (5/18) | 25.0% (3/12) | 33.3% (2/6) | 0.709 |
| [12.5%–50.9%] | [8.9%–53.2%] | [9.7%–70.0%] | ||
| Borderline AD + HP positive | 22.2% (4/18) | 33.3% (4/12) | 0% (0/6) | 0.109 |
| [9.0%–45.2%] | [13.8%–60.9%] | [0%–39.0%] | ||
| Borderline AD + pincer deformity | ||||
| Borderline AD + acetabular index ≤0° | 33.3% (1/3) | 0% (0/2) | 100% (1/1) | 0.083 |
| [6.1%–79.2%] | [0%–65.8%] | [20.7%–100%] | ||
| Borderline AD + RA | 66.7% (2/3) | 100% (2/2) | 0% (0/1) | 0.083 |
| [20.8%–93.9%] | [34.2%–100%] | [0%–79.3%] | ||
Data are shown as percentage [95% CI]. AD, acetabular dysplasia; FAI, femoroacetabular impingement; PGD, pistol grip deformity; HP, herniation pit; HNOR, head–neck offset ratio; RA, retroverted acetabulum.
Male versus female, evaluated with χ2 test. P-values of <0.05 were considered statistically significant.